UMB Enters Five-Year, $6 Million Partnership with MedImmune
March 24, 2014
New collaboration will strengthen SOP’s existing relationship with biopharmaceutical powerhouse and drive novel bioscience research across the State of Maryland and beyond.
Pharmapreneurship
SOP Researcher’s Entrepreneurism Recognized with Phase I Innovation Grant
February 3, 2014
Bruce Yu, PhD, to lead investigation of novel, inexpensive method to detect protein aggregation in biopharmaceutical drugs.
SOP Alumnus’ Entrepreneurial Lecture Imparts Valuable Life Lessons
December 4, 2013
Dr. John Gregory speaks to UMB faculty, staff, and students about his experience as an entrepreneur and offers tips for business success.
Rodriguez de Bittner Delivers Founders Week Kick-Off Lecture
October 17, 2013
Presentation spotlights social entrepreneurship and its role in solving some of health care’s biggest challenges.
Rodriguez de Bittner Named 2013 Founders Week Entrepreneur of the Year
October 7, 2013
Magaly Rodriguez de Bittner, PharmD ’83, BCPS, CDE, FAPhA, professor and chair of the Department of Pharmacy Practice and Science, recognized for her work as director of the Center for Innovative Pharmacy Solutions.
SOP Launches Groundbreaking Program to Engage Patients in Health Research
September 30, 2013
New program emphasizes patient-centered outcomes research to build and sustain relationships among patients, providers, and researchers.
Biological Mass Spectrometry Expert Joins PSC Faculty
September 17, 2013
David Goodlett, PhD, former professor and director of the Mass Spectrometry Center at the University of Washington School of Pharmacy, announced as department’s Isaac E. Emerson Chair of Pharmaceutical Sciences.
PHSR Professor Awarded University System’s Wilson H. Elkins Professorship
September 16, 2013
C. Daniel Mullins, PhD, will use award to expand his work in patient-centered outcomes and health disparities research in west Baltimore.
SOP Faculty Develop New, Promising Compound for Treatment of Chronic Pain
August 27, 2013
Initial studies indicate that compound is as powerful as morphine and also exhibits reduced tolerance with no toxic effects.
New Case Study Shows Maryland P3 Program Can Improve Employee Productivity
May 23, 2013
Employees at Chesapeake Public Schools experience decreased health care costs and improved productivity through participation in program’s diabetes management services.
SOP’s Maryland P3 Program Now Available in Pilot to Select State Employees
May 10, 2013
Pilot project for 5,000 state workers uses School’s expertise to develop, implement, and evaluate the effectiveness of comprehensive medication therapy management services.
Halethorpe Community Pharmacists Inducted into Dean’s Hall of Fame
April 17, 2013
George Garmer and Sherry Butler honored for their leadership, entrepreneurship, and passion for independent pharmacy.